On-Demand Webinars
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
Innovative Contamination Control: Enabling Integrity And Efficiency
10/15/2024
An integrated approach can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.
-
The Road To Approval: Viral Clearance Strategies For Non-Enveloped Viral Vectors
10/10/2024
Know the differences between designing a viral clearance study for non-enveloped viral vectors versus those for mAbs or recombinant proteins, and learn how to identify and remove viral contaminants.
-
The Successful Implementation Of A New Aseptic Filling Line
10/10/2024
Discover how a Quality by Design approach can streamline the development of new sterile product filling lines, featuring a real-life example illustrating its effectiveness.
-
Compressed Gas Risk Assessment: A Significant Step In Your CCS
10/10/2024
Learn the importance of compressed gas monitoring in ensuring product quality and compliance with EU GMP standards.
- Scalable by Design: Streamlining Cell Culture Media Manufacturing - rerun for Thermo email 10/10/2024
-
Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes
10/10/2024
Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.
-
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders Alzheimer's Disease
10/8/2024
Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
Validating Antibodies With Knock-Out Technologies
10/8/2024
Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
-
Microglia: Where We Came From And Where We Are Now
10/8/2024
Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.